Insight Pharma Reports: Market Data on the Diseases That Affect Women's Health & Fertility
09 juin 2016 11h30 HE
|
Insight Pharma Reports
NEEDHAM, MA--(Marketwired - June 09, 2016) - Insight Pharma Reports, a division of Healthtech Publishing, announces a series of leading market research reports focusing on disease that affect...
Insight Pharma Reports: New Report Data on Prenatal Diagnostics
06 juin 2016 13h00 HE
|
Insight Pharma Reports
NEEDHAM, MA--(Marketwired - June 06, 2016) - Insight Pharma Reports, a division of Healthtech Publishing, provides the life science sciences community the report entitled: Prenatal Diagnostics:...
CombiMatrix Comments on Additional Medical Policy Revisions to Reimburse for Recurrent Pregnancy Loss Testing
10 mai 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., May 10, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre-implantation genetic...
CombiMatrix to Present at the ROTH Conference
09 mars 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., March 09, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Comments on Revised Reimbursement Policies for Recurrent Pregnancy Loss
11 févr. 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 11, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Study Published in Genetics in Medicine
01 févr. 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 01, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Announces Commercial Launch of Microarray Testing for Stillbirth Analysis
28 janv. 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Jan. 28, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage...
New Data From Multi-Year Study of Pregnancy Loss Support Efficacy and Diagnostic Power of CombiMatrix’s Chromosomal Microarray Analysis
06 janv. 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage analysis...
CombiMatrix Announces Multicycle Offering for Pre-Implantation Genetic Screening and Improved Cost Efficiencies
16 déc. 2015 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Dec. 16, 2015 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage...
CombiMatrix Corporation to Hold 2015 Second Quarter Conference Call on August 5
29 juil. 2015 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., July 29, 2015 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) announces that it will release financial results for the quarter ended June 30, 2015 after market close on...